SG11201907695WA - Product and method for the treatment of bioprosthetic tissues - Google Patents
Product and method for the treatment of bioprosthetic tissuesInfo
- Publication number
- SG11201907695WA SG11201907695WA SG11201907695WA SG11201907695WA SG11201907695WA SG 11201907695W A SG11201907695W A SG 11201907695WA SG 11201907695W A SG11201907695W A SG 11201907695WA SG 11201907695W A SG11201907695W A SG 11201907695WA SG 11201907695W A SG11201907695W A SG 11201907695WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- treatment
- rue
- english
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Prostheses (AREA)
- Medicines Containing Plant Substances (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17157490.8A EP3366324A1 (fr) | 2017-02-22 | 2017-02-22 | Produit et procédé de traitement de tissus bioprothétiques |
| PCT/EP2017/080977 WO2018153525A1 (fr) | 2017-02-22 | 2017-11-30 | Produit et procédé pour le traitement de tissus bioprothétiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201907695WA true SG11201907695WA (en) | 2019-09-27 |
Family
ID=58108558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201907695WA SG11201907695WA (en) | 2017-02-22 | 2017-11-30 | Product and method for the treatment of bioprosthetic tissues |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11660375B2 (fr) |
| EP (2) | EP3366324A1 (fr) |
| JP (1) | JP2020508193A (fr) |
| KR (1) | KR20190121326A (fr) |
| CN (1) | CN110494171A (fr) |
| AU (1) | AU2017400910B2 (fr) |
| BR (1) | BR112019017295A2 (fr) |
| CA (1) | CA3054091A1 (fr) |
| ES (1) | ES2936112T3 (fr) |
| IL (1) | IL268865A (fr) |
| RU (1) | RU2019127523A (fr) |
| SG (1) | SG11201907695WA (fr) |
| WO (1) | WO2018153525A1 (fr) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55159760A (en) * | 1979-06-01 | 1980-12-12 | Sugiyama Sangyo Kagaku Kenkyusho | Healthy food |
| JPS57186463A (en) * | 1981-05-08 | 1982-11-16 | Nisshin Oil Mills Ltd:The | Production of mayonnaise-like acidic emulsion food product |
| JP3495082B2 (ja) * | 1994-04-13 | 2004-02-09 | 財団法人糧食研究会 | コレステロールの回収方法 |
| US5931969A (en) | 1994-07-29 | 1999-08-03 | Baxter International Inc. | Methods and apparatuses for treating biological tissue to mitigate calcification |
| JPH08173060A (ja) * | 1994-12-28 | 1996-07-09 | Q P Corp | コレステロール含有液状食品中のコレステロール除去方法 |
| BR0115106A (pt) * | 2000-11-01 | 2006-02-21 | Edwards Lifesciences Corp | métodos para a preparação de tecido bioprotético e dispositivos implantáveis compreendendo tal tecido bioprotético |
| US7989157B2 (en) * | 2005-01-11 | 2011-08-02 | Medtronic, Inc. | Solution for storing bioprosthetic tissue used in a biological prosthesis |
| US7579381B2 (en) * | 2005-03-25 | 2009-08-25 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
| CN101161293A (zh) * | 2006-10-12 | 2008-04-16 | 胡盛寿 | 异种生物组织材料的抗钙化改性方法 |
| US8357387B2 (en) * | 2007-12-21 | 2013-01-22 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
| WO2013090145A1 (fr) * | 2011-12-13 | 2013-06-20 | Boston Scientific Scimed, Inc. | Valvule cardiaque décalcifiante |
| EP2712633B1 (fr) * | 2012-10-02 | 2015-04-29 | Biotronik AG | Composants bioprothétiques pour un implant, notamment valves cardiaques biologiques partiellement réticulées |
| CN106190949B (zh) * | 2015-05-08 | 2020-04-10 | 上海微创心通医疗科技有限公司 | 一种干态动物源性胶原纤维组织材料及其制备方法和生物假体 |
-
2017
- 2017-02-22 EP EP17157490.8A patent/EP3366324A1/fr not_active Withdrawn
- 2017-11-30 ES ES17829940T patent/ES2936112T3/es active Active
- 2017-11-30 EP EP17829940.0A patent/EP3585451B1/fr active Active
- 2017-11-30 WO PCT/EP2017/080977 patent/WO2018153525A1/fr unknown
- 2017-11-30 RU RU2019127523A patent/RU2019127523A/ru not_active Application Discontinuation
- 2017-11-30 US US16/487,117 patent/US11660375B2/en active Active
- 2017-11-30 AU AU2017400910A patent/AU2017400910B2/en active Active
- 2017-11-30 SG SG11201907695WA patent/SG11201907695WA/en unknown
- 2017-11-30 CA CA3054091A patent/CA3054091A1/fr active Pending
- 2017-11-30 BR BR112019017295-5A patent/BR112019017295A2/pt not_active Application Discontinuation
- 2017-11-30 CN CN201780089366.2A patent/CN110494171A/zh active Pending
- 2017-11-30 JP JP2019565610A patent/JP2020508193A/ja active Pending
- 2017-11-30 KR KR1020197027202A patent/KR20190121326A/ko not_active Application Discontinuation
-
2019
- 2019-08-22 IL IL26886519A patent/IL268865A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019127523A (ru) | 2021-03-23 |
| BR112019017295A2 (pt) | 2020-03-31 |
| ES2936112T3 (es) | 2023-03-14 |
| EP3585451B1 (fr) | 2022-10-19 |
| CN110494171A (zh) | 2019-11-22 |
| RU2019127523A3 (fr) | 2021-03-23 |
| WO2018153525A1 (fr) | 2018-08-30 |
| CA3054091A1 (fr) | 2018-08-30 |
| AU2017400910B2 (en) | 2023-10-12 |
| AU2017400910A1 (en) | 2019-09-12 |
| JP2020508193A (ja) | 2020-03-19 |
| US20210213169A1 (en) | 2021-07-15 |
| EP3366324A1 (fr) | 2018-08-29 |
| EP3585451A1 (fr) | 2020-01-01 |
| US11660375B2 (en) | 2023-05-30 |
| KR20190121326A (ko) | 2019-10-25 |
| IL268865A (en) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201903857UA (en) | Antibodies to pd-1 and uses thereof | |
| SG11201805507UA (en) | Retractable heat source for aerosol generating article | |
| SG11201811184UA (en) | Lag -3 binding members | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201908971RA (en) | Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene | |
| SG11201908056QA (en) | Anti-par2 antibodies and uses thereof | |
| SG11201808476SA (en) | Recycling of polymer matrix composite | |
| SG11201903153PA (en) | Metal recovery process | |
| SG11201907948TA (en) | Formulations comprising pd-1 binding proteins and methods of making thereof | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201907774VA (en) | Sulfoximine glycosidase inhibitors | |
| SG11201808829VA (en) | Tdp-43 mitochondrial localization inhibitor for the treatment of neurodegenerative disease | |
| SG11201807949WA (en) | Engineered immunoglobulins with altered fcrn binding | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201900336YA (en) | Radioligands for imaging the ido1 enzyme | |
| SG11201805263TA (en) | Compositions and methods for detecting and treating esophageal cancer | |
| SG11201906313SA (en) | A polypeptide linker for preparing multispecific antibodies | |
| SG11201809671PA (en) | Imidazolone compounds as human neutrophil elastase inhibitors | |
| SG11201810123SA (en) | Treatment of intrahepatic cholestatic diseases | |
| SG11201805141QA (en) | Compositions and methods for detecting and treating gastric cancer | |
| SG11201809551TA (en) | Selection of bacterial strains useful in allergy treatment | |
| SG11201908888VA (en) | Compositions and methods for treating lung cancer | |
| SG11201809541UA (en) | Immune checkpoint inhibitors and cytotoxic t cells for the treatment of cancer |